CORE LABORATORIES NV's gross profit margin for the fourth quarter of its fiscal year 2015 has decreased when compared to the same period a year ago. Sales and net income fell significantly, but still managed to outperform when compared to the average company in its industry. CORE LABORATORIES NV has average liquidity. Currently, the Quick Ratio is 1.39 which shows that technically this company has the ability to cover short-term cash needs. The company's liquidity has decreased from the same period last year, indicating deteriorating cash flow.
At the same time, stockholders' equity ("net worth") has significantly decreased by 127.06% from the same quarter last year. Together, the key liquidity measurements indicate that it is relatively unlikely that the company will face financial difficulties in the near future.
STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. To learn more visit www.TheStreetRatings.com.
|Income Statement||Q4 FY15||Q4 FY14|
|Net Sales ($mil)||182.72||278.62|
|Net Income ($mil)||15.42||66.19|
|Balance Sheet||Q4 FY15||Q4 FY14|
|Cash & Equiv. ($mil)||22.49||23.35|
|Total Assets ($mil)||625.26||675.65|
|Total Debt ($mil)||430.99||356.0|
|Profitability||Q4 FY15||Q4 FY14|
|Gross Profit Margin||31.75||39.52|
|Return on Assets||18.36||38.1|
|Return on Equity||0.0||294.02|
|Debt||Q4 FY15||Q4 FY14|
|Share Data||Q4 FY15||Q4 FY14|
|Shares outstanding (mil)||42.41||43.64|
|Div / share||0.55||0.5|
|Book value / share||-0.56||2.01|
|Institutional Own %||n/a||n/a|
|Avg Daily Volume||653976.0||677807.0|
HOLD. The current P/E ratio indicates a significant discount compared to an average of 46.53 for the Energy Equipment & Services industry and a significant premium compared to the S&P 500 average of 20.88. Normally, for additional comaprison, we would look at the price-to-book ratio; however, this company's price-to-book ratio is negative making the value useless for comparisons. The price-to-sales ratio is well above both the S&P 500 average and the industry average, indicating a premium. Upon assessment of these and other key valuation criteria, CORE LABORATORIES NV proves to trade at a discount to investment alternatives within the industry.
|CLB 33.43||Peers 46.53||CLB 17.27||Peers 8.81|
Discount. A lower P/E ratio than its peers can signify a less expensive stock or lower growth expectations.
CLB is trading at a significant discount to its peers.
Premium. The P/CF ratio, a stock’s price divided by the company's cash flow from operations, is useful for comparing companies with different capital requirements or financing structures.
CLB is trading at a significant premium to its peers.
|CLB 28.24||Peers 31.62||CLB 185.72||Peers 8.15|
Average. An average price-to-projected earnings ratio can signify an industry neutral stock price and average future growth expectations.
CLB is trading at a valuation on par with its peers.
Premium. The PEG ratio is the stock’s P/E divided by the consensus estimate of long-term earnings growth. Faster growth can justify higher price multiples.
CLB trades at a significant premium to its peers.
|CLB NM||Peers 1.72||CLB -53.81||Peers -133.18|
Neutral. A lower price-to-book ratio makes a stock more attractive to investors seeking stocks with lower market values per dollar of equity on the balance sheet.
CLB's P/B is negative making this valuation measure meaningless.
Higher. Elevated earnings growth rates can lead to capital appreciation and justify higher price-to-earnings ratios.
CLB is expected to have an earnings growth rate that significantly exceeds its peers.
|CLB 4.75||Peers 1.62||CLB -26.52||Peers -21.44|
Premium. In the absence of P/E and P/B multiples, the price-to-sales ratio can display the value investors are placing on each dollar of sales.
CLB is trading at a significant premium to its industry.
Lower. A sales growth rate that trails the industry implies that a company is losing market share.
CLB significantly trails its peers on the basis of sales growth
Check Out Our Best Services for Investors
Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts
David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.
Every recommendation goes through 3 layers of intense scrutinyquantitative, fundamental and technical analysisto maximize profit potential and minimize risk.
More than 30 investing pros with skin in the game give you actionable insight and investment ideas.